authorTwo hundred consecutive clinical isolates of S. pneumoniae in 2005 and 2006 wereanalyzed for susceptibility to antimicrobials, pbp alterations and macrolide resistant gene expressions (2007 analysis). The results were compared with our previous data (2003 analysis). The average minimum inhibitory concentration (MIC) of penicillin G (PEN-G) in isolates with 1a^m/2x^m/2b^m decreased from 1.135±0.503 mg/L in the 2003 analysis to 0.872±0.540 mg/L in the 2007 analysis (p=0.0046). Isolates with 1a^m/2x^m/2b^m increased from 30.5% to 32.3% but the difference was not statistically significant (p=0.6979). Isolates with a MIC of clarithromycin ≥1.0 mg/L increased from 65.9% to 80.0% (p=0.0005). Isolates with ermB expression increased from 46.6%...
AbstractAntibacterial resistance in pneumococci is increasing worldwide, primarily against β-lactams...
The incidence of antimicrobial-resistant strains of Streptococcus pneumoniae has increased alarmingl...
and Streptococcus pneumoniae, and shortly thereafter, the United States Food and Drug Administration...
authorPenicillin binding protein (pbp) gene alterations of 328 clinical isolates of Streptococcus pn...
Streptococcus pneumoniae is an important human pathogen, causing about 100 millions of cases of dise...
Streptococcus pneumoniae is an important bacterial pathogen responsible for respiratory infections, ...
Streptococcus pneumoniae and Group A Streptococci are frequent colonizers and major causative agents...
Despite increasing resistance in the pneumococcus over the past 30 years, there are few cases of tre...
We report the unusual involvement of altered PBP 2A in the development of β-lactam resistance i...
The genetic diversity of Streptococcus pneumoniae isolates ( ) recovered from cere-n = 291 brospinal...
We report the unusual involvement of altered PBP 2A in the development of β-lactam resistance i...
Heteroresistance to beta-lactam antibiotics has been mainly described for staphylococci, for which i...
AbstractObjective: To determine the prevalence of penicillin resistance and molecular characteristic...
Objectives: To investigate the effect of subinhibitory concentrations of ciprofloxacin, streptomycin...
Objectives: To investigate the effect of subinhibitory concentrations of ciprofloxacin, streptomycin...
AbstractAntibacterial resistance in pneumococci is increasing worldwide, primarily against β-lactams...
The incidence of antimicrobial-resistant strains of Streptococcus pneumoniae has increased alarmingl...
and Streptococcus pneumoniae, and shortly thereafter, the United States Food and Drug Administration...
authorPenicillin binding protein (pbp) gene alterations of 328 clinical isolates of Streptococcus pn...
Streptococcus pneumoniae is an important human pathogen, causing about 100 millions of cases of dise...
Streptococcus pneumoniae is an important bacterial pathogen responsible for respiratory infections, ...
Streptococcus pneumoniae and Group A Streptococci are frequent colonizers and major causative agents...
Despite increasing resistance in the pneumococcus over the past 30 years, there are few cases of tre...
We report the unusual involvement of altered PBP 2A in the development of β-lactam resistance i...
The genetic diversity of Streptococcus pneumoniae isolates ( ) recovered from cere-n = 291 brospinal...
We report the unusual involvement of altered PBP 2A in the development of β-lactam resistance i...
Heteroresistance to beta-lactam antibiotics has been mainly described for staphylococci, for which i...
AbstractObjective: To determine the prevalence of penicillin resistance and molecular characteristic...
Objectives: To investigate the effect of subinhibitory concentrations of ciprofloxacin, streptomycin...
Objectives: To investigate the effect of subinhibitory concentrations of ciprofloxacin, streptomycin...
AbstractAntibacterial resistance in pneumococci is increasing worldwide, primarily against β-lactams...
The incidence of antimicrobial-resistant strains of Streptococcus pneumoniae has increased alarmingl...
and Streptococcus pneumoniae, and shortly thereafter, the United States Food and Drug Administration...